Tyche Wealth Partners LLC Buys Shares of 2,249 STERIS plc (NYSE:STE)

Tyche Wealth Partners LLC bought a new stake in shares of STERIS plc (NYSE:STE) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 2,249 shares of the medical equipment provider’s stock, valued at approximately $462,000.

A number of other institutional investors and hedge funds have also made changes to their positions in STE. Ashton Thomas Securities LLC bought a new stake in shares of STERIS during the third quarter valued at approximately $25,000. Central Pacific Bank Trust Division increased its position in shares of STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 76 shares in the last quarter. Quarry LP bought a new stake in shares of STERIS during the third quarter valued at approximately $67,000. Asset Dedication LLC increased its position in shares of STERIS by 54.8% during the third quarter. Asset Dedication LLC now owns 291 shares of the medical equipment provider’s stock valued at $71,000 after acquiring an additional 103 shares in the last quarter. Finally, R Squared Ltd bought a new stake in shares of STERIS during the fourth quarter valued at approximately $78,000. Institutional investors own 94.69% of the company’s stock.

STERIS Trading Up 2.1 %

Shares of STERIS stock opened at $225.44 on Friday. The company’s fifty day simple moving average is $212.33 and its 200-day simple moving average is $224.59. The stock has a market capitalization of $22.25 billion, a PE ratio of 51.47 and a beta of 0.84. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 1.55.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.78% and a net margin of 8.02%. As a group, equities analysts anticipate that STERIS plc will post 9.11 earnings per share for the current year.

STERIS Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be given a dividend of $0.57 per share. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.01%. STERIS’s payout ratio is 52.05%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on STE shares. Needham & Company LLC restated a “hold” rating on shares of STERIS in a report on Friday, November 8th. Stephens restated an “overweight” rating and issued a $240.00 target price on shares of STERIS in a report on Thursday. StockNews.com cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 29th. JMP Securities restated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a report on Thursday. Finally, Piper Sandler raised their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday. One analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $258.75.

Insider Activity

In other STERIS news, SVP Cary L. Majors sold 1,682 shares of STERIS stock in a transaction on Monday, November 25th. The shares were sold at an average price of $217.32, for a total value of $365,532.24. Following the sale, the senior vice president now directly owns 11,372 shares in the company, valued at approximately $2,471,363.04. The trade was a 12.88 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.14% of the company’s stock.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.